Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Brain Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Neoplasm Metastasis 32Pancreatic Neoplasms 30Prostatic Neoplasms 24Lung Neoplasms 21Carcinoma, Hepatocellular 21Melanoma 16Breast Neoplasms 12Liver Neoplasms 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Head and Neck Neoplasms 7Kidney Neoplasms 6Gliosarcoma 6Sarcoma 5Glioma 5Central Nervous System Neoplasms 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Colorectal Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 3Recurrence 3Radiation Injuries 3Pain 3Ovarian Neoplasms 3Fallopian Tube Neoplasms 3

Interventions

Gefitinib 3Erlotinib Hydrochloride 3sotorasib 1pralsetinib 1osimertinib 1ficlatuzumab 1exemestane 1entinostat 1durvalumab 1cobimetinib 1camrelizumab 1Tyrosine Kinase Inhibitors 1Radiosurgery 1Prednisone 1Pemetrexed 1Leuprolide 1Dasatinib 1Carboplatin 1Afatinib 1AZD3759 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Respiratory Tract Diseases × Radiosurgery × Clear all
NCT02904954 2023-10-11

Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer

Weill Medical College of Cornell University

Phase 2 Completed
60 enrolled 12 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡